$RCPT Recent News U.S. benchmarks teeter on major

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$RCPT Recent News

U.S. benchmarks teeter on major support 11:46 a.m. Sept. 30, 2014 - Michael Ashbaugh
U.S. benchmarks teeter on major support 11:22 a.m. Sept. 30, 2014 - Michael Ashbaugh
Nasdaq Composite violates first support 12:38 p.m. Sept. 15, 2014 - Michael Ashbaugh
RadioShack dives on results; Tyson extends drop 3:36 p.m. June 10, 2014 - Sue Chang
Pep Boys shares rise after earnings results 5:49 p.m. June 9, 2014 - Wallace Witkowski
Receptos shares surge 40% on MS drug study result 4:46 p.m. June 9, 2014 - Wallace Witkowski

Receptos (RCPT) Hits New Lifetime High 37 min ago - TheStreet.com
Receptos lead product successful in Phase 2 for UC at higher dose 6:25 p.m. Oct. 27, 2014 - Seeking Alpha
Receptos Reports Promising Results for Ulcerative Colitis Drug 5:30 p.m. Oct. 27, 2014 - The Wall Street Journal Interactive Edition
Surprising Stocks That Performed Best for Billionaires in 2014 8:48 a.m. Oct. 27, 2014 - TheStreet.com
EC approves ulcerative colitis med 11:31 a.m. Oct. 22, 2014 - Seeking Alpha
Forward Pharma on deck for IPO 8:33 a.m. Oct. 7, 2014 - Seeking Alpha
Receptos (RCPT) Reaches New Lifetime High Today 10:17 a.m. Sept. 29, 2014 - TheStreet.com
Multiple Sclerosis Drugs Could Transform Market Again 5:07 p.m. Sept. 26, 2014 - Investors Business Daily
InsiderInsights.com Daily Round Up 9/24/14: Mercer International, OPKO Health, New Media, CTI BioPharma 8:17 a.m. Sept. 25, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up 9/20/14: OPK, RSG, VHC, GMAN 6:06 a.m. Sept. 22, 2014 - Seeking Alpha
UPDATE: Credit Suisse Reiterates On Receptos Inc Ahead Of Investor Call 7:19 a.m. Sept. 15, 2014 - benzinga.com
Trade-Ideas: Receptos (RCPT) Is Today's New Lifetime High Stock 9:49 a.m. Sept. 11, 2014 - TheStreet.com
Fraud Allegations Cause 21Vianet Group To Plunge 1:24 p.m. Sept. 10, 2014 - TheStreet.com
Receptos MS Drug Yields More Good Data; Stock Jumps 10:58 a.m. Sept. 10, 2014 - Investors Business Daily
Today's Dead Cat Bounce Stock: Receptos (RCPT) 9:58 a.m. Sept. 10, 2014 - TheStreet.com
4 Biotechs That Might Be Bought Soon 10:53 a.m. Aug. 29, 2014 - Investors Business Daily
Receptos Up 8%; Wedbush Sees Possible Takeover 3:43 p.m. Aug. 25, 2014 - benzinga.com
InsiderInsights.com Daily Round Up: 8/15/14 3:06 a.m. Aug. 17, 2014 - Seeking Alpha
Receptos (RCPT) Shares March Higher, Can It Continue? - Tale of the Tape 9:57 a.m. Aug. 15, 2014 - Zacks.com
Receptos Inc Stock Upgraded (RCPT) 11:11 a.m. Aug. 14, 2014 - TheStreet.com


Receptos Reports Positive Phase 2 Results for TOUCHSTONE Trial of RPC1063 in Ulcerative Colitis 4:02 p.m. Oct. 27, 2014 - GlobeNewswire
Receptos Announces First Patient Treated With Anti-Interleukin-13 Antibody in Phase 2 Trial for Eosinophilic Esophagitis 8:01 a.m. Oct. 3, 2014 - GlobeNewswire
Critical Alerts For FuelCell Energy, Receptos Inc., HD Supply Holdings Inc., Westport Innovations and Organovo Released By InvestorsObserver 9:31 a.m. Sept. 11, 2014 - PR Newswire - PRF
Receptos Announces Oral Podium Presentation at MS Boston 2014 8:02 a.m. Sept. 10, 2014 - GlobeNewswire
Flagship Ventures Appoints Agricultural Industry Leader Robert Berendes as Venture Partner 9:00 a.m. Aug. 25, 2014 - PR Newswire - PRF
Receptos to Present at Wedbush PacGrow Life Sciences Conference 8:01 a.m. Aug. 8, 2014 - GlobeNewswire
Receptos to Hold Second Quarter 2014 Financial Results Conference Call and Webcast 4:04 p.m. Aug. 7, 2014 - GlobeNewswire
Receptos Announces Appointment of Mary Szela and Richard Heyman, Ph.D. to Board of Directors 8:07 a.m. July 29, 2014 - GlobeNewswire
Flagship Ventures Adds Pharma Industry Veteran Roger J. Pomerantz, M.D., F.A.C.P. as Senior Partner 9:00 a.m. July 14, 2014 - PR Newswire - PRF
Clinical Trial Update, Recommendations for Approval, Share Repurchase Programs, and Closing of Public Offering - Analyst Notes on Medtronic, Regeneron, Lilly, United Therapeutics and Receptos 5:50 a.m. July 2, 2014 - PR Newswire - PRF
Receptos Announces Closing of Underwritten Public Offering of Common Stock 9:35 a.m. June 24, 2014 - GlobeNewswire
Receptos Announces Pricing of Underwritten Public Offering of Common Stock 7:44 p.m. June 18, 2014 - GlobeNewswire
Receptos Announces Proposed Underwritten Public Offering of Common Stock 4:09 p.m. June 17, 2014 - GlobeNewswire
Technical Update, Leadership Appointments, and Clinical Trial Results - Analyst Notes on Achillion, Nektar, CytRx, Galena and Receptos 5:20 a.m. June 12, 2014 - PR Newswire - PRF
Receptos Reports Positive Phase 2 Results for RPC1063 in Relapsing Multiple Sclerosis 4:06 p.m. June 9, 2014 - GlobeNewswire
Flagship Ventures Commences Its Sixth VentureLabs™ Fellowship Program Focused On Entrepreneurial Innovation 9:00 a.m. June 5, 2014 - PR Newswire - PRF
Receptos Reports First Quarter 2014 Financial Results 8:02 a.m. May 12, 2014 - GlobeNewswire
Receptos to Hold First Quarter 2014 Financial Results Conference Call and Webcast 8:01 a.m. May 7, 2014 - GlobeNewswire
Receptos to Present at Bank of America Merrill Lynch 2014 Health Care Conference 8:02 a.m. May 6, 2014 - GlobeNewswire
Receptos to Present at Deutsche Bank Securities Annual Healthcare Conference 8:02 a.m. May 1, 2014 - GlobeNewswire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UBCF Extends Pink Bag Event for Breast Cancer Aid

Updated Category News Views 2

Community Need Drives Event Extension October in Jonesboro just got a bit more hopeful for breast cancer survivors—it's not just about awareness anymore; it's about action. The United Breast Cancer Foundation (UBCF) has decided to extend its popular Pink Bag free shopping event through October 30th. What spurred this decision? Well, the overwhelming community demand,...

Continue Reading
AI Tool circMAC Enhances MicroRNA Mapping on circRNAs

Updated Category News Views 3

Mapping the Complex Maze of MicroRNA on Circular RNAs Pusan National University's brainiacs have cooked up something spicy for the bioinformatics world. They've developed this snazzy AI tool, circMAC, to unravel microRNA binding mysteries on circular RNAs. 'Why’s this such a big deal?' you ask. Well, these loop-shaped critters, circRNAs, play a backstage role in gene...

Continue Reading
Podium Surges Past $150M in AI ARR Milestone

Updated Category News Views 3

A New Era for Podium When the brass at Podium made a gamble on AI, they didn't just try squeezing it into their old business model. Oh no, they launched what feels like a startup within their existing empire—no half-measures, just full-throttle ambition. Fast forward two and a half years, and they've racked up over $150 million in annual recurring revenue from these...

Continue Reading
Labcorp, FDA Collaborate to Tackle Drug Abuse Risks

Updated Category News Views 2

Rethinking How We Evaluate Drug Abuse Potential Sometimes, the finance world gets a peek into something that ain't just about the numbers on a screen, something with real stakes beyond the bulls and bears. Labcorp's just thrown its hat in with the FDA and Charles River Laboratories in a collaboration that goes beyond just lining pockets. They're setting up to dissect how...

Continue Reading
Vertice P2P Aims to Transform Procurement Efficiency

Updated Category News Views 9

Vertice Dives Deeper into the Procurement Game Grab a coffee and let's talk some procurement—one of the least sexy, yet utterly essential parts of any operation. Vertice's latest announcement is anything but mundane. They're spiraling deeper into the procurement universe with their new Procure-to-Pay (P2P) capability, a bold expansion from their Intake-to-Procure (I2P)...

Continue Reading
Cognizant AI Nexus Aims to Tame Enterprise AI Chaos

Updated Category News Views 5

AI Investments Without Returns: The Current Scenario Well, wouldn't you know it? Enterprises have sunk a fortune into AI, and they're wagging their fingers once more at the mounting bills with little to show for it. Play the investment game long enough, and it seems you'll find the numbers don't always rub together and make sparks. This familiar tune of over-budget...

Continue Reading
TransPerfect Launches College Bowl Game in Puerto Rico

Updated Category News Views 2

Puerto Rico Welcomes College Football with Open Arms Imagine kicking towards the goalposts while the ocean breeze kisses your face—yep, that's what's happening in Puerto Rico this December. TransPerfect, a heavyweight in language and tech solutions, is rolling out the red carpet for the inaugural TransPerfect San Juan Bowl, and it’s not just a game. It’s a bold step...

Continue Reading
Carrier Drops $600M on U.S. Manufacturing Boost

Updated Category News Views 3

A Mighty Move in Manufacturing Carrier Global Corporation's recent muscle-flexing is something rarer than a golden goose in today's market—a $600 million thrust into beefing up U.S. manufacturing and engineering. You can't help but wonder if this is overzealous optimism or a meticulously calculated power play. Clocks don't tick this loudly without good reason, of...

Continue Reading
Innventure Investors Alert: Securities Investigation Looms

Updated Category News Views 6

Innventure's Murky Waters Just when you think you've seen it all, stuff like this reminds you nothing's safe in the market. The law folks at Stranch, Jennings & Garvey, PLLC are sniffing around Innventure, Inc. (NASDAQ: INV) like bloodhounds to see if there's been some hoodwinking going on. We're talking questions about funny business with a data center deal between...

Continue Reading
Xona's $250M Raise: GPS Transformation Sparks Debate

Updated Category News Views 5

The Satellite Race Heats Up: Xona's Ambitious Leap Hold onto your hats, folks, because Xona's making headlines with a $250 million infusion. This ain't just pocket change—it's part of a rocket-fueled mission to upend the GPS landscape. Imagine a world where GPS is 100 times stronger. That's the pitch, and folks, it's got the market buzzing. Valuation Rocketing: Investor...

Continue Reading

Top 5 Most Recently Viewed Articles

osapiens Attracts $100 Million Investment, Solidifying Unicorn Status

Updated Category News Views 125

osapiens Secures Major Funding Round osapiens, a leading firm in enterprise software dedicated to encouraging sustainable growth, has recently announced a significant financial milestone. The company has secured an impressive US$ 100 million in a Series C funding round, spearheaded by Decarbonization Partners, a collaboration between BlackRock and Temasek. This newfound...

Continue Reading
Microsoft Teams Partners with Thrive Global for Enhanced Wellbeing

Updated Category News Views 167

Microsoft and Thrive Global Join Forces for Employee Wellbeing Microsoft has embarked on an inspiring journey by partnering with Thrive Global, a company that specializes in behavior change strategies aimed at enhancing overall wellbeing. This collaboration aims to integrate a range of wellbeing resources seamlessly into the daily operations of Microsoft Teams, making it...

Continue Reading
Coventry First Challenges Abacus Lawsuit Over Life Settlements

Updated Category News Views 420

Coventry First LLC Files Motion to Dismiss Lawsuit Coventry First LLC, along with Co-Founder and Executive Chairman Alan H. Buerger, is taking a decisive stand against the lawsuit filed by Abacus Global Management, Inc. This move comes in response to a claim that Coventry believes lacks merit, particularly in light of recent industry changes. Key Developments Around the...

Continue Reading
AbbVie Announces Significant Dividend Increase for Shareholders

Updated Category News Views 222

AbbVie Declares Quarterly Dividend The board of directors at AbbVie Inc. (NYSE: ABBV) has announced a quarterly cash dividend of $1.55 per share. This decision reflects the company's ongoing commitment to providing value to its shareholders through dependable and substantial dividend distributions. Details and Timeline for the Dividend The announced dividend will be paid...

Continue Reading
GitLab's 'Ultimate' Strategy Drives Adoption and Stock Upgrades

Updated Category News Views 77

GitLab's Growing Demand for 'Ultimate' GitLab Inc (NASDAQ: GTLB) has recently experienced a notable uptick in the adoption of its 'Ultimate' offering, according to industry expert insights. The stock saw a boost when analyst Mike Cikos from Needham raised its rating from Hold to Buy, setting a price target of $70. This optimistic outlook is backed by GitLab's continued...

Continue Reading